Taho Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2017	FY 2016
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Market Capitalization	6,732	2,274	-	-	616	549
Market Cap Growth	99.47%	-	-	-	12.10%	-59.61%
Enterprise Value	6,345	2,074	-	-	430	279
Last Close Price	131.00	44.35	-	-	11.76	10.49
PS Ratio	865.43	-	-	-	49.65	15.25
PB Ratio	15.10	4.41	-	-	3.55	1.76
P/TBV Ratio	15.13	4.41	-	-	3.94	1.89
EV/Sales Ratio	-	-	-	-	34.70	7.75
Debt / Equity Ratio	0.03	0.03	0.11	-	0.01	0.00
Net Debt / Equity Ratio	-0.87	-0.93	-1.01	-1.15	-0.74	-0.72
Net Debt / EBITDA Ratio	2.30	2.85	1.76	1.84	1.40	2.41
Net Debt / FCF Ratio	2.25	2.89	1.94	1.67	0.92	2.17
Asset Turnover	0.02	-	0.01	-	0.05	0.09
Inventory Turnover	-	-	-	-	2.18	2.02
Quick Ratio	35.53	15.02	3.85	2.29	5.13	19.17
Current Ratio	35.74	15.09	3.91	2.39	5.70	20.53
Return on Equity (ROE)	-48.14%	-46.32%	-80.79%	-	-56.44%	-29.72%
Return on Assets (ROA)	-29.12%	-25.20%	-35.89%	-	-25.53%	-17.73%
Return on Capital Employed (ROCE)	-37.70%	-32.20%	-54.20%	-72.50%	-61.60%	-34.70%
Earnings Yield	-2.47%	-7.36%	-	-	-22.27%	-19.88%
FCF Yield	-2.55%	-7.29%	-	-	-22.48%	-18.79%
Buyback Yield / Dilution	-17.82%	-17.18%	-7.73%	31.26%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.